AcquisitionOther
Ikena Oncology, Inc. acquired Pionyr
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Ikena Oncology, Inc. -> Pionyr · $43 million
The capital from this acquisition allows us to accelerate and expand our clinical efforts in IK-930 and further support our comprehensive clinical plan for IK-595 as we continue to build value through both depth and breadth in our pipeline.
Open source record (SEC) ↗